id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_mtczmozd5zdwhb7tkw3hmbne4i	Alison G. Freifeld	Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America	2011.0	38	.pdf	application/pdf	34690	5012	57	agents in managing patients with cancer who experience chemotherapy-induced fever and neutropenia. invasive fungal infections has led to debate regarding optimal use of empirical or preemptive antifungal therapy, immediate treatment are the universal keys to managing neutropenic patients with fever and/or infection. The majority of patients who develop fever during neutropenia have no identifiable site of infection and no positive High-risk patients should initially receive IV empirical antibiotic therapy in the hospital. Candida esophagitis infections in high-risk patients, so empirical additions of acyclovir and/or fluconazole or another antifungal are appropriate. In low-risk patients without documented infection, continuing antibiotic therapy until resolution of both fever and Fluconazole prophylaxis is effective in reducing the risk of Candida infections in neutropenic patients, is of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. neutropenic patients at high risk for invasive fungal infection: a	./cache/work_mtczmozd5zdwhb7tkw3hmbne4i.pdf	./txt/work_mtczmozd5zdwhb7tkw3hmbne4i.txt